Evidence map›Paper›PMID 42478014›Full record

ArticleArchives of rheumatology2026

Why Fibromyalgia Criteria Keep Changing: A Systematic Review of Misclassification, Measurement, and Diagnostic Spillover.

Ali Gür

Abstract read
In one paragraph

Article in Archives of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ali GürDivision of Algology, Department of Physical Medicine and Rehabilitation, Gaziantep University Faculty of Medicine, Gaziantep, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsFibromyalgia is diagnosed without a definitive biomarker, so classification and diagnostic criteria carry unusual clinical and epidemiologic weight. This Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020-guided systematic review examined why fibromyalgia criteria keep changing and how those changes influence overdiagnosis, misdiagnosis, missed diagnosis, chronic widespread pain boundaries, comorbid rheumatic disease, sex ratios, vitamin D deficiency, and prevalence estimates. MATERIALS AND

methodsMEDLINE/PubMed, Scopus, and Web of Science Core Collection were searched from January 1, 1990 to March 4, 2026. Backward and forward citation tracking was added. Eligible records included criteria papers, validation and concordance studies, prevalence studies, health-system analyses, comorbidity studies, and digital or bodymap measurement studies. Fifty-eight records were included in the qualitative synthesis. Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) and Risk of Bias In Non-Randomized Studies of Interventions (ROBINS-I)-informed domains guided appraisal where appropriate.

resultsAcross criteria eras, revisions redistributed rather than eliminated diagnostic error. The 1990 criteria standardized research cohorts but depended on tender-point examination. The 2010/2011 criteria improved feasibility and symptom capture, yet increased vulnerability to regionalpain and high-distress misclassification. The 2016 revision introduced a generalized pain requirement and clarified that fibromyalgia can coexist with other disorders, improving boundary control but not resolving clinician- criteria discordance, sex-sensitive under-recognition, or comorbidityrelated diagnostic delay. Prevalence estimates vary partly because criteria architecture, sampling frame, pain-map methods, and case-finding purpose differ across studies.

conclusionThe 2016 criteria remain useful, but they are not a complete clinical diagnostic system. Future work should not merely add another threshold; it should combine generalized pain verification, dimensional severity reporting, comorbidity-aware interpretation, sex-sensitive screening, and explicit separation of chronic widespread pain from fibromyalgia. Cite this article as: Gür A. Why fibromyalgia criteria keep changing: A systematic review of misclassification, measurement, and diagnostic spillover. Arch Rheumatol. 2026;41(3):155-167.

Identifiers

PMID42478014
PMCPMC13401112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.